Please use this identifier to cite or link to this item: http://hdl.handle.net/2067/1843
DC FieldValueLanguage
dc.contributor.authorD'Amici, Gian Maria-
dc.contributor.authorTimperio, Anna Maria-
dc.contributor.authorGevi, Federica-
dc.contributor.authorGrazzini, Giuliano-
dc.contributor.authorZolla, Lello-
dc.date.accessioned2011-04-01T06:45:53Z-
dc.date.available2011-04-01T06:45:53Z-
dc.date.issued2010-
dc.identifier.citationD'Amici, G.M. et al. 2010. Recombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluation. "Electrophoresis" 31(16): 2730-2739it
dc.identifier.issn0173-0835-
dc.identifier.urihttp://hdl.handle.net/2067/1843-
dc.descriptionL'artcoo è disponibile sul sito dell'editore http://onlinelibrary.wiley.com/it
dc.description.abstractFactor VIII is an important glycoprotein involved in hemostasis. Insertion of expression vectors containing either the full-length cDNA sequence of human factor VIII (FLrFVIII) or B-domain deleted (BDDrFVIII) into mammalian cell lines results in the production of recombinant factor VIII (rFVIII) for therapeutic usage. Three commercially available rFVIII concentrates (Advates, Helixate NexGens and Refactos), either FLrFVIII or BDDrFVIII, were investigated by 1- and 2-DE and MS. The objective of this study was to compare the heterogeneity and the high purity of both rFVIII preparations before and after thrombin digestion. In particular, the 2-D gel was optimized to better highlight the presence of contaminants and many unexpected proteins. Recombinant strategies consisting of insertion of expression vectors containing BDDrFVIII and FLrFVIII resulted in homogeneous and heterogeneous protein products, respectively, the latter consisting in a heterogeneous mixture of various B-domain-truncated forms of the molecule. Thrombin digestion of all the three rFVIII gave similar final products, plus one unexpected fragment of A2 domain missing 11 amino acids. Regarding the contaminants, Helixate NexGens showed the presence of impurities, such as Hsp70 kDa, haptoglobin and proapolipoprotein; Refactos showed glutathione S-transferase and b-lactamase, whereas Advates apparently did not contain any contaminants. The proteomic approach will contribute to improving the quality assurance and manufacturing processes of rFVIII concentrates. In this view, the 2-DE is mandatory for revealing the presence of contaminants.it
dc.language.isoenit
dc.publisherWiley-Blackwellit
dc.subject2-DEit
dc.subjectHemophilia Ait
dc.subjectProteomicsit
dc.subjectRecombinant factor VIIIit
dc.titleRecombinant clotting factor VIII concentrates: Heterogeneity and high-purity evaluationit
dc.typeArticleit
dc.identifier.doi10.1002/elps.201000216it
item.fulltextWith Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:DISA - Archivio della produzione scientifica
Files in This Item:
File Description SizeFormat
D'amici et al.pdf82.04 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations 5

21
Last Week
0
Last month
0
checked on Sep 18, 2023

Page view(s)

180
Last Week
0
Last month
4
checked on Mar 27, 2024

Download(s)

229
checked on Mar 27, 2024

Google ScholarTM

Check

Altmetric


All documents in the "Unitus Open Access" community are published as open access.
All documents in the community "Prodotti della Ricerca" are restricted access unless otherwise indicated for specific documents